Open AccessRectal nitric oxide as biomarker in the treatment of inflammatory bowel disease: Respondersversusnonresponders
Author(s) -
Tryggve Ljung,
Steffan Lundberg,
Mark Varsanyi,
Catharina Johansson,
Peter T. Schmidt,
Max Herulf,
Jon O. Lundberg,
Per M. Hellström
Publication year - 2006
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v12.i21.3386
Subject(s) - ulcerative colitis , biomarker , inflammatory bowel disease , gastroenterology , medicine , crohn's disease , nitric oxide , colectomy , refractory (planetary science) , colitis , colorectal cancer , disease , cancer , chemistry , biology , biochemistry , astrobiology
To explore rectal nitric oxide (NO) as biomarker of treatment response in ulcerative colitis (UC) and Crohn's disease (CD), and examine relationships between rectal NO, mucosal expression of NO synthases (NOS), and pro-inflammatory cytokines.